GGrantIndex
← Search

CLINICAL TRIAL: AN OPEN-LABEL, MULTICENTER, PHASE II STUDY EVALUATING THE SAFETY

$5,116M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →